A Randomized Trial of Combination Anastrozole Plus Gefitinib and of Combination Fulvestrant Plus Gefitinib in the Treatment of Postmenopausal Women With Hormone Receptor Positive Metastatic Breast Cancer
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-012-1997-5
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2012
Authors
Publisher
Springer Science and Business Media LLC